Affibody AB receives SwedenBIO award 2013

Non-Regulatory

May 22, 2013

Solna, Sweden, May 22, 2013. Affibody wins SwedenBIO Award 2013 for its unique business model.

Affibody received the SwedenBIO Award 2013 at life sciences industry organization
SwedenBIO’s annual conference in Stockholm on May 21, 2013. The award is the
industry’s own award which aims to focus the attention on Swedish life science
companies that have achieved significant national and international recognition
during the previous year.

During
2012 Affibody took several critical steps forward and saw its revenues grow
significantly. Additionally business development activities yielded two new key
collaborations during the year including the company’s first clinical stage
collaboration.

Commenting
on the award, David Bejker, Chief Executive Officer of Affibody AB, said: “We are thrilled to win this award. It is
rewarding for me and my colleagues to receive this acknowledgement for our work
in the past few years. Our increasing number of collaboration partners
validates our unique platforms that are products of world leading Swedish
research. Looking ahead we see great opportunity to further expand our business
and continue to create value from our technology platforms.”

Further
information about the award can be found in the attached press release from
SwedenBIO (in Swedish).